4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...

4/11/2022India Hopes 'Pharma City' Will Break China's Grip on Industry

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

4/10/2022 Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk (Th...

4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

4/10/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...

4/8/2022Propella Enters Licensing Deal with Jiangsu Aosaikang for Development ...

4/8/2022Recent Executive Moves

4/8/2022Drug R&D and Product Registration News Digest April 2022 (1)

4/8/2022China Approves 18 New Drugs in Q1/2022 (PharmCube)

4/8/2022China Views Pay-For-Delay Deal as Antitrust Offence, Lawyer Cautions (...

4/7/2022The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...

4/7/2022Pregene, CellPoint to Co-develop anti-BCMA CAR-T Cell Therapy in Europ...

4/7/2022CDE Solicits Comments on the Draft Q&As on Research Conditions of Diss...

4/7/2022CDMO Asymchem Completes Expansion of  Chinese Manufactuing Facilitie...

4/6/2022Novartis, BeiGene's Tislelizumab Gets EMA Review in Esophageal, Lung C...

4/6/2022AstraZeneca Licenses Harbour BioMed's CLDN18.2xCD3 Bispecific Antibody...

4/6/2022Everest Med Enters into an MOU for Partnership with CR Pharma for its ...

4/6/2022USCC: Chinese Companies Listed on Major U.S. Stock Exchanges

4/6/2022Evolution of Innovative Drug R&D in China (Nature)

4/5/2022The Chinese Supreme People's Court Released New Interpretation on Seve...

4/5/2022Hasten Biopharma Acquires Five Cardiovascular and Metabolism Drugs fro...

4/5/2022Chinese VMS OTC Market Up 8.4% in 2021, Driven by Higher Health Awaren...

4/5/2022Investment into Chinese Biotech Falls Abruptly as U.S. Steps Up Scrut...

4/4/2022U.S. Passes Bill to Curb Supply Reliance on China, with Focus on Ph...

4/3/2022Daiichi Sankyo Disposes Chinese Rights of Cravit Formulations and Loca...

4/3/2022SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet T...

4/3/2022Bloomberg: China Weighs Giving U.S. Full Access to Audits of Most Firm...

4/1/2022CASI Pharma Added to SEC List of Firms Facing Possible U.S. Delisting

Page:159/789 Total number of articles:23668: [First][<<] [157] [158] [159] [160] [161] [>>] [End]